VI Partners
Healthcare &a; Technology Venture Capital since 2001
Business Model:
Revenue: $20.7M
Employees: 51-200
Rankings
Detailed VI Partners Information
Geographic Data
Address: Postfach 2146
City:
State: zug
Zip: 86 6302
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Linkedin
Crunchbase
Metrics
8,540,939Website Global Rank
293Website Monthly Traffic
Twitter Followers
Description
Healthcare &a; Technology Venture Capital since 2001. We build bridges between entrepreneurs’ dreams and successful companies. We enable savvy investors to partner with the best start-up companies. VI Partners is a Swiss venture capital firm providing university spin-off&s;s as well as other promising start-up companies with capital, coaching and networks. VI Partners is the advisor to multiple funds. The first fund was established by McKinsey &a; Company and the Swiss Federal Institute of Technology in Zürich (ETHZ) in 2001.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2010 | SmallRivers | Seed Round | - |
| 1/2020 | iOnctura | Series A | 16.6M |
| 4/2015 | L.E.S.S. | Series A | 3.1M |
| 10/2016 | Inositec | Seed Round | 1.4M |
| 5/2011 | Delenex Therapeutics | Series A | 19.3M |
| 9/2005 | Xigen | Series A | 21M |
| 7/2019 | SMART VALOR | Equity | 3.3M |
| 8/2019 | Araris Biotech | Seed Round | 2.6M |
| 5/2010 | Pay by Shopping (deal united) | Series A | 6.2M |
| 3/2016 | Amal Therapeutics | Series A | 3.1M |
| 1/2017 | Flytrex | Series A | 0 |
| 2/2013 | Windeln.de | Series C | 19.6M |
| 6/2017 | Lambda Health System | Seed Round | 771.2k |
| 10/2020 | Araris Biotech | Seed Round | 0 |
| 9/2010 | Nexthink | Series A | 4.9M |
| 4/2006 | Endoart | Series C | 0 |
| 7/2020 | iOnctura | Series A | 5.8M |
| 9/2013 | Sonic Emotion | Funding Round | 3M |
| 10/2021 | Acodis | Convertible Note | 0 |
| 4/2014 | JenaValve Technology | Series C | 0 |
| 2/2020 | JenaValve Technology | Series D | 0 |
| 8/2015 | JenaValve Technology | Series C | 26.5M |
| 7/2013 | JenaValve Technology | Series C | 62.5M |
| 6/2010 | JenaValve Technology | Series B | 22.7M |
| 2/2021 | Medlumics | Venture Round | 21.8M |
| 4/2021 | CeQur SA | Series C | 0 |
| 3/2023 | Oculis | Post-IPO Equity | 0 |
| 11/2013 | Endosense | Series C | 41.2M |
| 11/2017 | Xeltis | Series C | 53M |
| 2/2006 | Visonys | Venture Round | 1.3M |
| 4/2022 | Unique | Seed Round | 6M |
| 5/2021 | Oculis | Series C | 0 |
| 9/2021 | Ledgy | Series A | 10M |
| 7/2022 | Morgen | Pre Seed Round | 0 |
| 10/2015 | Sequana Medical | Series C | 0 |
| 12/2014 | Xeltis | Series B | 33.5M |
| 5/2016 | Gamaya | Series A | 3.2M |
| 1/2007 | Nexthink | Corporate Round | 3.3M |
| 6/2004 | Neocutis | Series A | - |
| 11/2012 | Endosense | Series C | 40.3M |
| 10/2010 | MerLion Pharma | Series C | 0 |
| 8/2015 | Kuros Biosciences | Post-IPO Equity | 15.3M |
| 10/2022 | Vara | Series A | 4.5M |
| 4/2014 | Sequana Medical | Series C | 26.1M |
| 7/2013 | Edimer | Series B | 18M |
| 10/2022 | Sibylla Biotech | Series A | 0 |
| 10/2005 | Kuros Biosciences | Post-IPO Equity | 0 |
| 1/2005 | Kuros Biosciences | Post-IPO Equity | 0 |
| 9/2005 | NemeriX | Series B | 0 |
| 9/2007 | NemeriX | Series C | 0 |
| 2/2020 | JenaValve Technology | Venture Round | 50M |
| 6/2019 | Gamaya | Series B | 0 |
| 4/2015 | UniKey Technologies | Series A | 10M |
| 8/2009 | Spinelab | Series B | 10.2M |
| 8/2017 | PicoDRILL | Series A | 6M |
| 1/2019 | MESA Imaging | Series A | 0 |
| 4/2007 | Spinelab | Series A | 3.3M |
| 1/2004 | NemeriX | Venture Round | 0 |
| 5/2003 | Avalon Photonics | Venture Round | 0 |
| 3/2011 | Sequana Medical | Series B | 25.5M |
| 1/2015 | Genkyotex | Post-IPO Equity | 0 |
| 8/2006 | ESBATech | Series B | 41M |
| 12/2015 | Xeltis | Series B | 3.3M |
| 8/2008 | ESBATech | Series B | 22M |
| 9/2022 | Ledgy | Series B | 22M |
| 1/2017 | Advanon | Series A | 13.3M |
| 3/2022 | Altoida | Series A | 0 |
| 10/2022 | Araris Biotech | Series A | 24M |
| 8/2022 | Skribble | Series A | 10.2M |
| 12/2018 | Ledgy | Seed Round | 1.4M |
| 4/2022 | Ninox | Venture Round | 0 |
| 11/2013 | Delenex Therapeutics | Series A | 8M |
| 12/2016 | Altoida | Seed Round | 1.2M |
| 9/2017 | Amal Therapeutics | Series B | 9.5M |
| 11/2018 | Amal Therapeutics | Series B | 32.6M |
| 7/2011 | Pay by Shopping (deal united) | Series B | - |
| 10/2009 | Endosense | Series B | 0 |
| 5/2019 | Altoida | Series A | 6.3M |
| 1/2007 | Sequana Medical | Series A | - |
| 5/2018 | Altoida | Convertible Note | 750k |
| 4/2006 | Nexthink | Seed Round | 1.3M |
| 11/2009 | Activaero | Series A | 15.8M |
| 1/2010 | CeQur | Series A | 29.6M |
| 9/2015 | CeQur | Series C | 100M |
| 5/2012 | Spinelab | Series C | 4.8M |
| 12/2020 | HighLife | Series C | - |
| 12/2015 | Equippo.com | Seed Round | - |
| 6/2009 | Edimer Pharmaceuticals | Series A | 22M |
| 2/2010 | SilentSoft | Venture Round | 2.1M |
| 9/2007 | Ganymed Pharmaceuticals | Series C | 47.5M |
| 2/2005 | Covalys Biosciences | Series B | 2.6M |
| 11/2010 | Delenex Therapeutics | Series A | 14M |
| 2/2011 | Activaero | Series A | 0 |
| 5/2006 | Mobileye, an Intel Company | Private Equity Round | 15M |
| 4/2022 | Picterra | Series A | 0 |
| 1/2023 | Acodis | Series A | 6.5M |
| 7/2022 | Morgen | Pre Seed Round | 0 |
| 4/2022 | Ninox | Venture Round | 0 |
| 4/2022 | Picterra | Series A | 0 |
| 4/2022 | Unique | Seed Round | 0 |
| 3/2022 | Altoida | Series A | 0 |
| 10/2021 | Acodis | Convertible Note | 0 |
| 9/2021 | Ledgy | Series A | 0 |
| 5/2021 | Oculis | Series C | 0 |
| 4/2021 | CeQur | Series C | 0 |
| 2/2021 | Medlumics | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
